Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Purpose To develop a model of X-linked inhibitor of apoptosis (XIAP) down regulation in colorectal cancer cell lines. This may be used to determine whether combination strategies have clinical potential.Methods A series of clones were developed using short hairpin RNA (shRNA) against XIAP stably expressed in HCT116 cells. XIAP mRNA and protein levels were established by RT-PCR and Immunoblot, respectively. GeneChip microarrays confirmed XIAP knockdown and absence of compensation by other IAP members.Results Four XIAP knockdown cell lines show 82-93% reduction in XIAP mRNA and 67-89% reduction in protein when compared to four luciferase control cell lines. XIAP knockdown sensitises cells to rhTRAIL by a factor of 3, to paclitaxel and docetaxel by a factor of >2 and, to a lesser extent, radiotherapy (20% enhancement).Conclusions Clinical trials with XIAP antisense continue, and these data suggest combination studies with agents such as rhTRAIL and taxanes should be undertaken.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies have shown that XIAP can promote resistance of CRC cells to apoptosis induced by multiple tumor treatments [251,252,253].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [251]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Subsequent P values were subjected to multiple testing correction using Benjamini and Hochberg’s method for controlling the false discovery rate [ 25 ].”
MethodBioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 1×
“Data were analysed using Bioconductor 1.8 [ 19 ] running on R 2.3.0 [20].”
MethodInfluentialSmyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766 · cited 2×
“Paclitaxel and docetaxel were added over a concentration range to exponentially growing cells and incubated for 72 h prior to SRB assay [ 26 ].”
Methodlimma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218 · cited 1×
“Expression measures were calculated using the ‘AVy’ package’s Robust Multichip Average (RMA) default method [ 21 ].”
MethodSummaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., & Takahashi, R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00341-0 · Cited by 1,116 · cited 1×
“Other factors which have been reported as showing interactions with XIAP on literature review (MURR1 [28], akt2 [29], smac/Diablo [30], XAF1 [31], htra2/omi [ 32 ], apaf1 [12], GSPT1 [33] and NFKB [34]) were unchanged (Fig. 2a, b). The above results con-Wrm speciWc and stable 80% down regulation of XIAP with no impact…”
BackgroundMechanism of XIAP-Mediated Inhibition of Caspase-9
Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., & Shi, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00054-6 · Cited by 719 · cited 1×
“The main function of XIAP is inhibition of executioner caspases 3 and 7 [3] and initiator caspase 9 [ 4 ], and XIAP is the only member of the family to inhibit both phases of the cascade directly [5].”
Background
Research works printed but not linked: 1
- Ranson M, Ward T, Cummings J et al (2005) A Phase 1 Trial of AEG35156 (XIAP antisense) administered as a 7-day continuous intravenous infusion in patients with advanced tumors. Clin Cancer Res 11(24, Part 2):8965s–9216s
Cited by
Trarbach, T., Moehler, M., Heinemann, V, Köhne, C.-H., Przyborek, M., Schulz, C., Sneller, V, Gallant, G., & Kanzler, S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605507 · Cited by 180
“Experimental manipulation of FLIP (Wilson et al, 2007) and XIAP (Toscano et al, 2008; Connolly et al, 2009; Wilson et al, 2009) has confirmed their critical role in mediating resistance against TRAIL-R-dependent apoptosis.”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Inhibitors of apoptosis: clinical implications in cancer
Mohamed, M. S., Bishr, M. K., Almutairi, F. M., & Ali, A. G. (2017) · Apoptosis · doi:10.1007/s10495-017-1429-4 · Cited by 159
“Using the antisense approach, inhibition of XIAP has been reported to improve tumor control by radiotherapy and chemotherapy [216].”
BackgroundLing, X., Cao, S., Cheng, Q., Keefe, J. T., Rustum, Y. M., & Li, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045571 · Cited by 141
Svoboda, M., Šáňa, J., Fabián, P., Kocáková, I., Gombošová, J., Nekvindová, J., Radová, L., Vyzula, R., & Slabý, O. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-195 · Cited by 136
“It was shown that knockdown of XIAP in vitro lead to sensitization of colon cancer cells to irradiation [30].”
Background
Metadata
- Authors
- Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S.
- Affiliations
- Edinburgh Cancer Research (GB)
- Cancer Research UK (GB)
- University of Cambridge (GB)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Connolly, Kate
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2008-11-26
- Volume
- 64
- Issue
- 2
- Pages
- 307-316
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W2001633094
- Cited by
- 34
- References
- 49
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 5
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Chemotherapy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (C96/A4743)
- University of Manchester
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- XIAP, X-linked inhibitor of apoptosis, HCT116 cells, colorectal cancer, shRNA, gene knockdown, TRAIL, paclitaxel, docetaxel, radiosensitization, apoptosis inhibitor, combination therapy
- MeSH terms
- Animals, Colonic Neoplasms, Flow Cytometry, Gamma Rays, Humans, Mice, Nude, RNA, Messenger, Tumor Cells, Cultured, Immunoblotting, Reverse Transcriptase Polymerase Chain Reaction, Caspases, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Xenograft Model Antitumor Assays, RNA, Small Interfering, Taxoids, Cell Proliferation, Mice, X-Linked Inhibitor of Apoptosis Protein, TNF-Related Apoptosis-Inducing Ligand, Gene Knockdown Techniques, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. https://app.cochat.ai/papers/10.1007/s00280-008-0872-x
- The paper
- Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S. (2009). Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-008-0872-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.